Forward Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-4,480
Closed -$494K 146
2018
Q3
$494K Sell
4,480
-1,030
-19% -$107K 0.08% 101
2018
Q2
$514K Buy
5,510
+145
+3% +$12.5K 0.08% 116
2018
Q1
$446K Buy
5,365
+73
+1% +$6.49K 0.07% 143
2017
Q4
$482K Sell
5,292
-150
-3% -$12.5K 0.05% 137
2017
Q3
$415K Buy
5,442
+200
+4% +$15.1K 0.05% 146
2017
Q2
$394K Buy
5,242
+480
+10% +$33.3K 0.03% 149
2017
Q1
$310K Buy
4,762
+226
+5% +$13.3K 0.03% 153
2016
Q4
$250K Sell
4,536
-9,810
-68% -$538K 0.02% 186
2016
Q3
$811K Sell
14,346
-1,210
-8% -$59.3K 0.06% 126
2016
Q2
$650K Sell
15,556
-2,257
-13% -$104K 0.05% 147
2016
Q1
$762K Sell
17,813
-1,231
-6% -$52K 0.06% 145
2015
Q4
$863K Buy
19,044
+2,855
+18% +$120K 0.07% 143
2015
Q3
$629K Sell
16,189
-12,327
-43% -$494K 0.05% 180
2015
Q2
$1.04M Buy
28,516
+12,720
+81% +$402K 0.06% 177
2015
Q1
$456K Buy
+15,796
New +$441K 0.03% 246

Other funds holding PRAH

Forward Management's PRAH Position: Q4 2018 in Review

Forward Management sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2018, closing a stake of 4,480 shares — an estimated $494K sold.

Forward Management first reported a position in PRAH in Q1 2015 and held it in 15 quarters. The position peaked at $1.04M in Q2 2015. 334 funds tracked by Wall St. Rank hold PRAH as of Q4 2018.

  • Forward Management reported no remaining PRA Health Sciences, Inc. position as of Q4 2018 after selling out during the quarter.
  • Forward Management sold 4,480 PRA Health Sciences, Inc. shares in Q4 2018, an estimated $494K.
  • Forward Management first reported a position in PRA Health Sciences, Inc. in Q1 2015 and held it in 15 quarters.
  • Forward Management's PRA Health Sciences, Inc. position peaked at $1.04M in Q2 2015.
  • 334 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2018.

Based on Forward Management's 13F filing for Q4 2018, filed 1 Feb 2019.